A comparative study of two PODXL antibodies in 840 colorectal cancer patients

BACKGROUND: Podocalyxin (PODXL) is a transmembrane sialomucin, whose aberrant expression and/or allelic variation associates with poor prognosis and unfavourable clinicopathological characteristics in different cancers. Membranous expression of PODXL has been suggested to be an independent marker of...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Kaprio, Tuomas, Hagström, Jaana, Fermér, Christian, Mustonen, Harri, Böckelman, Camilla, Nilsson, Olle, Haglund, Caj
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2014
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4107962/
https://ncbi.nlm.nih.gov/pubmed/25004935
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-494
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller